Kaleido Biosciences Inc. (KLDO)
NASDAQ · Healthcare
Kaleido Biosciences Inc. Operating Income 2016–2021
Kaleido Biosciences Inc. annual/quarterly operating income history and growth rate from 2016 to 2021. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Kaleido Biosciences Inc. operating income for the quarter ending December 31, 2021 was -19.7 M, a 2.07% increase year-over-year.
- Kaleido Biosciences Inc. operating income for the twelve months ending December 31, 2021 was -87.7 M.
- Kaleido Biosciences Inc. annual operating income for 2021 was -87.7 M, a 11.15% increase from 2020.
- Kaleido Biosciences Inc. annual operating income for 2020 was -78.9 M, a 8.98% decrease from 2019.
- Kaleido Biosciences Inc. annual operating income for 2019 was -86.7 M, a 42.81% increase from 2018.
- Kaleido Biosciences Inc. annual operating income for 2018 was -60.7 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Kaleido Biosciences Inc. Operating Income — FAQ
Kaleido Biosciences Inc. (KLDO) operating income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Kaleido Biosciences Inc.'s operating income?
Kaleido Biosciences Inc. (KLDO) reported operating income of -$88M for fiscal 2021.
Where can I see KLDO's operating income history?
The chart and table above show Kaleido Biosciences Inc.'s operating income by year and by quarter, including the growth rate.